Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: APLS

Apellis Pharmaceuticals, Inc.

Healthcare | Biotechnology
$41.03 as of 2026-09-04 21:42 UTC
Market Cap$5.2B
Volume28.64M
EPS (TTM)$0.20

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a $5.2B biotechnology company trading at $41.03 — 205.2× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 21:42 UTC.

APLS no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.

Key facts

Quote
Price$41.03
Market cap$5.2B
Volume28.64M shares
Valuation
P/E (TTM)205.15×
EV/EBITDA83.90×
EPS (TTM)$0.20
Price/book14.18×
Return on equity6.05%

Revenue, margins & earnings

FY2021: net loss $746M on revenue $67M$67MFY2021FY2022: net loss $652M on revenue $75M$75MFY2022FY2023: net loss $529M on revenue $397M$397MFY2023FY2024: net loss $198M on revenue $781M$781MFY2024FY2025 Net income: $22MFY2025 Taxes & interest: $33MFY2025 Operating costs: $948M$1.00BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
No filings archived yet. Search EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-05-14
Most recent filed transactions — May 2026:
  • 2026-05-14Dunlop A. SinclairD-7,961—
  • 2026-05-14Chopas James GeorgeVP/Chief Accounting OfficerA5,625—
  • 2026-05-14Chopas James GeorgeVP/Chief Accounting OfficerA8,394—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Apellis Pharmaceuticals, Inc. do?

Apellis Pharmaceuticals, Inc. is a biotechnology company, listed on NASDAQ as APLS.

What is APLS's valuation?

APLS trades at $41.03, 205.15× trailing earnings, 83.90× EV/EBITDA, as of 2026-09-04.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-04 21:42 UTC. This page is also available as JSON at /api/data?ticker=APLS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for APLS and 5,000+ tickers.

Create a free account — keep APLS
For your agent
GET /api/data?ticker=APLS

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt